Transgene expression in malignant glioma using a replication-defective adenoviral vector containing the Egr-1 promoter: activation by ionizing radiation or uptake of radioactive iododeoxyuridine.
about
Systemic therapy for cervical cancer with potentially regulatable oncolytic adenovirusesTranscriptional Targeting in Cancer Gene TherapyGenetically engineered HSV in the treatment of glioma: a review.Gene therapy in the CNS.Construction of targeted plasmid vector pcDNA3.1-Egr.1p-p16 and its expression in pancreatic cancer JF305 cells induced by radiation in vitroConditionally replicating adenoviruses for cancer treatment.Combination of PEI-Mn0.5Zn0.5Fe2O4 nanoparticles and pHsp 70-HSV-TK/GCV with magnet-induced heating for treatment of hepatoma.Targeted polymeric nanoparticles for cancer gene therapy.Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final resultsEnhanced EJ Cell Killing of (125)I Radiation by Combining with Cytosine Deaminase Gene Therapy Regulated by Synthetic Radio-Responsive PromoterCombination of human tumor necrosis factor-alpha (hTNF-alpha) gene delivery with gemcitabine is effective in models of pancreatic cancer.New complex Ad vectors incorporating both rtTA and tTS deliver tightly regulated transgene expression both in vitro and in vivo.Control of transgene expression using local hyperthermia in combination with a heat-sensitive promoter.A radiation-controlled molecular switch for use in gene therapy of cancer.Early growth response-1 gene (Egr-1) promoter induction by ionizing radiation in U87 malignant glioma cells in vitro.Modification of vascular tone using iNOS under the control of a radiation-inducible promoter.Radio-responsive recA promoter significantly increases TNFalpha production in recombinant clostridia after 2 Gy irradiation.Optimization of radiation controlled gene expression by adenoviral vectors in vitro.
P2860
Q21144267-4ABF6949-3BBB-404E-A143-D6B1F3B7C99FQ24791038-0A29C776-CF0F-4312-9279-D06A03315374Q33827571-9A7EF711-5CAE-4DC1-8CF6-1FBD08534B1DQ33837123-A6417852-E47C-4EA2-AE5C-197AE9576778Q34604821-E41ACB3D-08F4-497F-AAC1-930A5D9A33B0Q35967313-34DBB8BB-58EA-4031-83F7-5CFB0D758D31Q36307231-B59817E1-1DD6-4D3C-B063-BB6EA0F42274Q36416427-985197BA-402E-45BC-B040-1786E174BB11Q36764997-9AEA3E7C-C5FB-41FB-8EB2-2D33A74125CEQ38834565-72F1BCDC-526F-4F9C-88C5-28E2256E07ECQ39851146-51604C1C-099E-48F6-92C6-9A4E2D4A0FAFQ40468763-F4312B61-835D-44DB-8456-DC68E8BD8647Q40880232-AAECCBA3-F2E3-4052-9BB2-E29068964AD9Q43685592-16790DC5-B911-4FA2-A657-22A4BC504D52Q43849887-8F4D8638-E7CF-40A0-8E79-7EA413000A65Q45869573-ED919AE1-7D2B-436A-9CD5-7CD24B522C12Q45879277-B841D69D-BD49-4604-A9BC-C8E3016CFEB6Q45882347-DF49D0CE-28E8-4DE0-B73A-3DFC15686732
P2860
Transgene expression in malignant glioma using a replication-defective adenoviral vector containing the Egr-1 promoter: activation by ionizing radiation or uptake of radioactive iododeoxyuridine.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Transgene expression in malign ...... radioactive iododeoxyuridine.
@en
Transgene expression in malign ...... radioactive iododeoxyuridine.
@nl
type
label
Transgene expression in malign ...... radioactive iododeoxyuridine.
@en
Transgene expression in malign ...... radioactive iododeoxyuridine.
@nl
prefLabel
Transgene expression in malign ...... radioactive iododeoxyuridine.
@en
Transgene expression in malign ...... radioactive iododeoxyuridine.
@nl
P2093
P1433
P1476
Transgene expression in malign ...... radioactive iododeoxyuridine.
@en
P2093
P304
P356
10.1089/HUM.1998.9.10-1409
P577
1998-07-01T00:00:00Z